Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Mar;24(2):191-219.
doi: 10.1007/s12282-016-0732-1. Epub 2016 Oct 31.

Recent development of targeted approaches for the treatment of breast cancer

V L Maruthanila  1 , R Elancheran  1 , A B Kunnumakkara  2 , S Kabilan  3 , Jibon Kotoky  4
Affiliations
Review

Recent development of targeted approaches for the treatment of breast cancer

V L Maruthanila et al. Breast Cancer. 2017 Mar.

Abstract

Breast cancer is the most prominent cause of cancer death in women worldwide. The highlights of this review are to provide an overview of the targeted therapeutic agents, challenges with metastatic breast cancer (MBCa), mechanisms of action through Hedgehog/Gli 1 signaling pathway and future prospective. Over a decade of success, several drugs have been approved and are in the advanced stages of clinical trials that target the receptors such as estrogen receptor, growth factor receptor, receptor activator of nuclear factor kappa-B, etc. Currently, several monoclonal antibodies are also used for the treatment of breast cancer. Advances in understanding tumor biology, particularly signaling pathways such as Notch signaling pathway, Hedgehog/Gli 1 signaling pathway, and inhibitors are considered to be important for bone metastasis. These studies may provide vital information for the design and development of new strategies with respect to efficacy, reduction of the side effects, and treatment strategies.

Keywords: Angiogenesis; Breast cancer; Estrogen receptor; Growth factor receptor inhibitors; Hedgehog/Gli 1 signaling; Immunomodulators.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

MeSH terms

LinkOut - more resources